Dystrophic calcification of the prostate after cryotherapy.
Dru C, Bender L.
Case Rep Urol. 2014;2014:471385. doi: 10.1155/2014/471385. Epub 2014 Dec 7.
Cryotherapy of prostate cancer.
Loening S, Hawtrey C, Bonney W, Narayana A, Culp DA.
Prostate. 1980;1(3):279-86. doi: 10.1002/pros.2990010303.
[Adenocarcinoma of the prostate].
Dvorácek J.
Cas Lek Cesk. 1998 Aug 31;137(17):515-21.
Current status of HIFU and cryotherapy in prostate cancer--a review.
Aus G.
Eur Urol. 2006 Nov;50(5):927-34; discussion 934. doi: 10.1016/j.eururo.2006.07.011. Epub 2006 Jul 28.
Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy.
Izawa JI, Busby JE, Morganstern N, Vakar-Lopez F, Scott SM, Pisters LL.
BJU Int. 2006 Sep;98(3):554-8. doi: 10.1111/j.1464-410X.2006.06347.x.
Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease.
Cresswell J, Asterling S, Chaudhary M, Sheikh N, Greene D.
BJU Int. 2006 May;97(5):969-74. doi: 10.1111/j.1464-410X.2006.06073.x.
Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study.
Pyrgidis N, Chaloupka M, Ebner B, Volz Y, Weinhold P, Marcon J, Eismann L, Stief CG, Schulz GB, Apfelbeck M.
BJU Int. 2025 Aug;136(2):306-313. doi: 10.1111/bju.16746. Epub 2025 Apr 19.
Focal Therapy for Prostate Cancer: Available Technologies, Patient Selection, Follow-Up Protocols and Reported Outcomes.
Pow-Sang J, Bechara GR.
Arch Esp Urol. 2025 Nov;78(9):1124-1131. doi: 10.56434/j.arch.esp.urol.20257809.147.
Hypothermia during transurethral resection of prostate.
Carpenter AA.
Urology. 1984 Feb;23(2):122-4. doi: 10.1016/0090-4295(84)90003-7.
[Comparative statistics on complication rate in transurethral electroresections (TUR), cryotherapy and adenectomy of prostate].
Steffens L.
Z Urol Nephrol. 1974 Mar;67(3):201-4.
